Stem cell treatment for early-onset Parkinson's
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a new stem cell treatment called NouvNeu001 for people with early-onset Parkinson's disease. The goal is to see if it's safe and if it can help improve movement and daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- Your Parkinson's symptoms started when you were 50 or younger (early-onset).
- When your symptoms are at their worst, you can still walk without help (Hoehn-Yahr stages 2 to 4).
- You have not had brain surgery or stem cell therapy for Parkinson's before.
- You are healthy enough for brain surgery (good blood counts, no serious heart/lung problems, no active cancer or infections).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.
This trial tests a new stem cell treatment for people with Parkinson's disease. It's for those whose symptoms affect daily life and who still respond to levodopa but find it less effective over time.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
Hear when a new Early-onset Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.